| Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2 (NCT01160705) | Cancer Trials Ireland | 2009-11-01 |
| Preoperative Magnetic Resonance (MR) Imaging of Prostate Cancer (NCT01347320) | Oslo University Hospital | 2009-11-01 |
| Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer (NCT01020448) | Ipsen | 2009-11-01 |
| Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent (NCT01025479) | AstraZeneca | 2009-11-01 |
| Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers (NCT00984919) | Barbara Ann Karmanos Cancer Institute | 2009-11-01 |
| MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer (NCT01094665) | University Health Network, Toronto | 2009-11-01 |
| Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer (NCT01618851) | Georgetown University | 2009-11-01 |
| Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP (NCT03790995) | KU Leuven | 2009-10-01 |
| Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer (NCT00901342) | Dendreon | 2009-10-01 |
| ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer (NCT00959959) | LTN PHARMACEUTICALS, INC. | 2009-10-01 |
| The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing (NCT00851292) | Amphia Hospital | 2009-10-01 |
| A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer (NCT01000948) | Aarhus University Hospital | 2009-10-01 |
| Post-operative or Early Salvage XRT and ADT for High Risk PCa (NCT00949962) | European Organisation for Research and Treatment of Cancer - EORTC | 2009-10-01 |
| Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer (NCT01020305) | Sandy Srinivas | 2009-10-01 |
| A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer (NCT00992745) | Molecular Insight Pharmaceuticals, Inc. | 2009-10-01 |
| Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer (NCT00953576) | Dana-Farber Cancer Institute | 2009-09-29 |
| A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer (NCT00984321) | Memorial Sloan Kettering Cancer Center | 2009-09-22 |
| Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer (NCT00976755) | Swiss Cancer Institute | 2009-09-14 |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer (NCT00970203) | Roswell Park Cancer Institute | 2009-09-01 |
| MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy (NCT00963300) | University of Texas Southwestern Medical Center | 2009-09-01 |
| Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer (NCT00985738) | University of Colorado, Denver | 2009-09-01 |
| Study Using WST11 in Patients With Localized Prostate Cancer (NCT00975429) | Steba Biotech S.A. | 2009-09-01 |
| Prostate Cancer Antigen 3 (PCA-3) Gene Project (NCT01177436) | Assistance Publique Hopitaux De Marseille | 2009-09-01 |
| Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer (NCT00936390) | Radiation Therapy Oncology Group | 2009-09-01 |
| The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation Therapy (NCT01676480) | Inge Holm | 2009-09-01 |
| Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer (NCT00922129) | St. Joseph's Healthcare Hamilton | 2009-09-01 |
| FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer (NCT01168479) | UMC Utrecht | 2009-09-01 |
| A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer (NCT00992186) | Centocor Research & Development, Inc. | 2009-09-01 |
| Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis (NCT00918645) | University of California, Davis | 2009-09-01 |
| Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment (NCT00928603) | Università Vita-Salute San Raffaele | 2009-09-01 |
| F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer (NCT00963755) | University of Lausanne Hospitals | 2009-08-01 |
| Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer (NCT00953277) | Axogen Corporation | 2009-08-01 |
| Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients (NCT00884273) | Ferring Pharmaceuticals | 2009-08-01 |
| Periperal Blood Lymphocytes During Prostate RT (NCT01899391) | University Health Network, Toronto | 2009-08-01 |
| Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer (NCT00957606) | Odense University Hospital | 2009-08-01 |
| Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer (NCT00753220) | Bostwick Laboratories | 2009-08-01 |
| Proton Radiation Therapy in Treating Patients With Prostate Cancer (NCT01045226) | Abramson Cancer Center at Penn Medicine | 2009-08-01 |
| An Exploration of Genetic Testing for Prostate Cancer Susceptibility (NCT00997464) | Royal Marsden NHS Foundation Trust | 2009-08-01 |
| Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy (NCT00888654) | Barbara Ann Karmanos Cancer Institute | 2009-08-01 |
| Lycopene or Green Tea for Men at Risk of Prostate Cancer (NCT01105338) | University of Bristol | 2009-08-01 |
| Use of Hypothermia During Robotic Prostatectomy (NCT00915031) | University of California, Irvine | 2009-08-01 |
| Lenalidomide and Paclitaxel in Prostate Cancer (NCT00933426) | M.D. Anderson Cancer Center | 2009-08-01 |
| Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate (NCT00919022) | Bayer | 2009-08-01 |
| Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy (NCT00969111) | Proton Collaborative Group | 2009-08-01 |
| A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function (NCT02001571) | Cougar Biotechnology, Inc. | 2009-08-01 |
| A Long Term Safety Study of Degarelix in Patients With Prostate Cancer (NCT00967018) | Ferring Pharmaceuticals | 2009-08-01 |
| Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer (NCT00969202) | San Diego Radiosurgery | 2009-08-01 |
| Ultrasound-Guided Navigation in Robot-Assisted Laparoscopic Radical Prostatectomy (NCT00956904) | Johns Hopkins University | 2009-08-01 |
| A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17 (NCT00951535) | Cancer Trials Ireland | 2009-07-20 |
| Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome (NCT01441687) | City of Hope Medical Center | 2009-07-14 |
| Active Surveillance for Cancer of the Prostate (ASCaP) (NCT00949819) | Jonsson Comprehensive Cancer Center | 2009-07-04 |
| Postoperative Pain Control for Prostatectomy (NCT00913068) | Nova Scotia Health Authority | 2009-07-01 |
| Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients (NCT00879619) | John P. Fruehauf | 2009-07-01 |
| High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer (NCT00987675) | University College London Hospitals | 2009-07-01 |
| New Markers for Treatment Response to Radiotherapy in Prostate Cancer (NCT06159998) | University of Basel | 2009-07-01 |
| A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy (NCT00887458) | Johns Hopkins University | 2009-07-01 |
| Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer (NCT00887640) | Duke University | 2009-07-01 |
| Window Study of ZD4054 in Metastatic Prostate Cancer (NCT01168141) | The Christie NHS Foundation Trust | 2009-07-01 |
| High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer (NCT00988130) | University College London Hospitals | 2009-07-01 |
| Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade (NCT00945477) | Illinois CancerCare, P.C. | 2009-07-01 |
| Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer (NCT00946881) | Steba Biotech S.A. | 2009-07-01 |
| Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy (NCT00922818) | Maimonides Medical Center | 2009-06-01 |
| Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients (NCT00919035) | Oncology Specialists, S.C. | 2009-06-01 |
| A Study of Pre-operative Metformin in Prostate Cancer (NCT00881725) | University Health Network, Toronto | 2009-06-01 |
| Novel Peptide Vaccination for Patients With Advanced Prostate Cancer (NCT01225471) | Iwate Medical University | 2009-06-01 |
| Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer (NCT00928174) | Queen's Medical Center | 2009-06-01 |
| 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer (NCT00859781) | Weill Medical College of Cornell University | 2009-06-01 |
| A Trial of Degarelix in Patients With Prostate Cancer (NCT00946920) | Ferring Pharmaceuticals | 2009-06-01 |
| Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration (NCT00878436) | NYU Langone Health | 2009-06-01 |
| Modifications to Radical Prostatectomy: Feasibility Study (NCT00928850) | Memorial Sloan Kettering Cancer Center | 2009-06-01 |
| MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate (NCT01028885) | Abramson Cancer Center at Penn Medicine | 2009-06-01 |
| An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate (NCT00913263) | Lidds AB | 2009-06-01 |
| Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer Subjects (NCT00918229) | BioProtect | 2009-06-01 |
| Atkins Diet and Prostate Cancer Clinical Trial (NCT00932672) | Duke University | 2009-06-01 |
| Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer (NCT00989105) | Cancer Research UK | 2009-06-01 |
| Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer (NCT00911118) | Memorial Sloan Kettering Cancer Center | 2009-05-26 |
| Performance Evaluation of the AMS CONTINUUM™ Device (NCT00894933) | American Medical Systems | 2009-05-01 |
| Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer (NCT00921193) | Navotek Medical, Ltd. | 2009-05-01 |
| Prostate Cancer Symptom Management for Low Literacy Men (NCT00983710) | Baylor College of Medicine | 2009-05-01 |
| Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg (NCT00919477) | AstraZeneca | 2009-05-01 |
| Perioperative Changes of Cognitive Function According to Jugular Vein Insufficiency in Robot-assisted Prostatectomy (NCT01905488) | Yonsei University | 2009-05-01 |
| Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy (NCT00895310) | University of California, Davis | 2009-05-01 |
| Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study (NCT01376661) | St. Joseph Hospital of Orange | 2009-05-01 |
| Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis (NCT00798187) | M.D. Anderson Cancer Center | 2009-05-01 |
| Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer (NCT00909558) | Envita Medical Center, Inc. | 2009-05-01 |
| A Study of Degarelix in Patients With Prostate Cancer (NCT00928434) | Ferring Pharmaceuticals | 2009-05-01 |
| Study of Immunotherapy to Treat Advanced Prostate Cancer (NCT00861614) | Bristol-Myers Squibb | 2009-05-01 |
| Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer (NCT00918385) | Duke University | 2009-05-01 |
| Tailored Web-Based Intervention for Cancer Patients and Family Caregivers (NCT01415089) | University of Michigan | 2009-05-01 |
| Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer (NCT00916123) | Weill Medical College of Cornell University | 2009-05-01 |
| Radiotherapy of the Prostate and the Pelvic Lymph Nodes After Neoadjuvant Antihormonal Treatment (NCT01903408) | Heidelberg University | 2009-05-01 |
| Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer (NCT00887198) | Janssen Research & Development, LLC | 2009-04-28 |
| An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin (NCT00923104) | National Cancer Institute (NCI) | 2009-04-23 |
| A Study of Patients Receiving High-Dose Rate Brachytherapy (NCT00924027) | National Cancer Institute (NCI) | 2009-04-14 |
| Prostate Conformal Cryotherapy (NCT00877682) | M.D. Anderson Cancer Center | 2009-04-06 |
| Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer (NCT00833248) | Ferring Pharmaceuticals | 2009-04-01 |
| Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer (NCT00895115) | University of Medicine and Dentistry of New Jersey | 2009-04-01 |
| Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer (NCT00831233) | Ferring Pharmaceuticals | 2009-04-01 |
| Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer (NCT00849121) | University of Wisconsin, Madison | 2009-03-16 |
| An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ... (NCT00924092) | National Cancer Institute (NCI) | 2009-03-13 |